Advanced biomimetic nanomedicines for cell-based therapeutics: prospects and challenges
- 1Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, 130000, China
- 2Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, 130000, China. [email protected]
Abstract
Advanced biomimetic nanomedicines offer cell-based therapeutics to mimic biological behaviors for improved targeting, immune evasion, and integration with living cells. This review critically examines recent innovations in biomimetic nanocarriers especially leveraging from cell membranes, membrane proteins, or native cellular structures to support cell therapies. These systems aid in prolonging circulation, reducing immunogenicity, and directing therapeutic cells to disease sites. Membrane-coated nanoparticles, metal-phenolic network-based nanovaccines, and stem-cell-membrane-coated carriers have therapeutic potential but challenges of manufacturing, scalability, quality control, in vivo stability, and regulatory barriers are present. To overcome these challenges, substituted hybrid membrane formulations, bio-responsive release mechanisms, and modular design are adopted. This review aims to guide future research toward clinical viable biomimetic nanomedicines for cell-based therapies.
Related
- Cell-derived biomimetic nanomedicines: Emerging theranostic platforms for precision management of atherosclerosis.
- Toward Mild Conditions for N2 Activation: Progress and Challenges from Nitrogenase to Biomimetic Artificial Catalysts
- Cell Membrane-Coated Nanoparticles as Biomimetic Drug Delivery Systems: Design, Therapeutic Applications, and Translational Challenges.
- Functionalized metal-organic frameworks as smart nanoplatforms: advancing tumor precision therapy through post-synthetic surface tailoring, challenges, and prospects for clinical translation.
- Advanced Drug Delivery in Pediatric Neurology: Developmental Barriers, Nanocarrier Strategies, and Translational Challenges.
BibTeX
@article{wang2026advanced,
title = {{Advanced biomimetic nanomedicines for cell-based therapeutics: prospects and challenges}},
author = {Yue Wang and Liangliang Zhao and Ying Zou and Lili Nie},
journal = {Journal of Biological Engineering},
year = {2026},
month = may,
doi = {10.1186/s13036-026-00694-1},
url = {https://doi.org/10.1186/s13036-026-00694-1},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Advanced biomimetic nanomedicines for cell-based therapeutics: prospects and challenges
AU - Yue Wang
AU - Liangliang Zhao
AU - Ying Zou
AU - Lili Nie
PY - 2026
DA - 2026/05/18
JO - Journal of Biological Engineering
DO - 10.1186/s13036-026-00694-1
UR - https://doi.org/10.1186/s13036-026-00694-1
AB - Advanced biomimetic nanomedicines offer cell-based therapeutics to mimic biological behaviors for improved targeting, immune evasion, and integration with living cells. This review critically examines recent innovations in biomimetic nanocarriers especially leveraging from cell membranes, membrane proteins, or native cellular structures to support cell therapies. These systems aid in prolonging circulation, reducing immunogenicity, and directing therapeutic cells to disease sites. Membrane-coated nanoparticles, metal-phenolic network-based nanovaccines, and stem-cell-membrane-coated carriers have therapeutic potential but challenges of manufacturing, scalability, quality control, in vivo stability, and regulatory barriers are present. To overcome these challenges, substituted hybrid membrane formulations, bio-responsive release mechanisms, and modular design are adopted. This review aims to guide future research toward clinical viable biomimetic nanomedicines for cell-based therapies.
SN - 1754-1611
ER -